Dr. Kilburn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
111 Michigan Ave NW
Center for Cancer and Blood disorders
Washington, DC 20010Phone+1 202-476-2800- Is this information wrong?
Summary
- I am board certified in pediatric hematology and oncology as well as clinical pharmacology. I care for children with newly diagnosed and recurrent brain and spinal cord tumors. My research focuses on the development and translation of new therapies for children with brain tumors with a particular focus on novel therapies for glioma and medulloblastoma and combination therapies with focused ultrasound.
Education & Training
- Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2004 - 2007
- Eastern Virginia Medical SchoolResidency, Pediatrics, 2001 - 2004
- Eastern Virginia Medical SchoolClass of 2001
Certifications & Licensure
- DC State Medical License 2010 - 2024
- TX State Medical License 2007 - 2011
- VA State Medical License 2001 - 2004
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System Start of enrollment: 2009 Feb 25
- PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children Start of enrollment: 2012 Dec 13
- Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors Start of enrollment: 2015 Jul 14
- Join now to see all
Publications & Presentations
PubMed
- PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma.Kilburn, L. B., Kilburn, L. B., Ryan J Duchatel, Evangeline R Jackson, Sarah G Parackal, Dylan Kiltschewskij, Izac J Findlay, Abdul Mannan, Dilana E Staudt, Bryce C Th...> ;The Journal of Clinical Investigation. 2024 Feb 6
- 4 citationsPhase I trial of panobinostat in children with diffuse intrinsic pontine glioma: A report from the Pediatric Brain Tumor Consortium (PBTC-047).Michelle Monje, Tabitha Cooney, John Glod, Jie Huang, Cody J Peer, Damien Faury, Patricia Baxter, Kim Kramer, Alicia Lenzen, Nathan J Robison, Lindsay Kilburn, Anna Vi...> ;Neuro-Oncology. 2023 Dec 8
- 2 citationsFirst-in-human sonodynamic therapy with ALA for pediatric diffuse intrinsic pontine glioma: a phase 1/2 study using low-intensity focused ultrasound : Technical commun...Adriana Fonseca, Javad Nazarian, Chima Oluigbo, John S Myseros, Roger J Packer, Robert F Keating, Kilburn, L. B., Lindsay Kilburn, Hasan R Syed> ;Journal of Neuro-Oncology. 2023 Apr 1
- Join now to see all
Journal Articles
- Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid BiopsyEugene I Hwang, Cassie Kline, Soonmee Cha, Michael Prados, Lindsay B Kilburn, Nalin Gupta, Roger J Packer, Suresh N Magge, Clinical Cancer Research
Press Mentions
- SonALAsense Forges Ahead with First Patient Dosing for Devastating Childhood Brain CancerSeptember 13th, 2022
- “Liquid Biopsies” Could Track Diffuse Midline GliomasAugust 21st, 2019
Professional Memberships
- Member
- Society of Neuro-OncologyMember
Hospital Affiliations
- Children's National HospitalWashington, District of Columbia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: